Brief: CStone Pharmaceuticals Sees Total Revenue For Year To Be Not Less Than RMB475.0 Mln

CStone Pharmaceuticals

02/02/2023 09:04

Feb 2 (Reuters) - CStone Pharmaceuticals  2616.HK :
    * SEES  TOTAL REVENUE OF GROUP FOR YEAR TO BE NOT LESS THAN
RMB475.0 MILLION
    * EXPECTED RESULTS FOR REVENUE DUE TO SALES OF MARKETED
PRODUCTS
LIKE PRECISION MEDICINES AND ROYALTY INCOME FROM SUGEMALIMAB
    * SEES LOSS FOR YEAR EXCLUDING SHARE-BASED PAYMENT EXPENSES
OF
GROUP  NOT MORE THAN RMB800 MLN
    * EXPECTED DECREASE IN LOSS DUE TO INCREASED REVENUE FROM
MARKETED
PRODUCTS, AMONG OTHERS

Further company coverage:  2616.HK 
 ((Reuters.Briefs@thomsonreuters.com;))